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Selective suppression of excessive GluN2C
expression rescues early epilepsy in a tuberous
sclerosis murine model
N. Lozovaya1,2,3,*, S. Gataullina1,2,3,*, T. Tsintsadze1,2,*, V. Tsintsadze1,2, E. Pallesi-Pocachard1,2, M. Minlebaev1,2,4,
N.A. Goriounova1,2, E. Buhler1,2, F. Watrin1,2, S. Shityakov5, A.J. Becker6, A. Bordey7, M. Milh8, D. Scavarda8,
C. Bulteau3,9, G. Dorfmuller3,9, O. Delalande9, A. Represa1,2, C. Cardoso1,2, O. Dulac3,9,10, Y. Ben-Ari1,2
& N. Burnashev1,2
Tuberous sclerosis complex (TSC), caused by dominant mutations in either TSC1 or TSC2
tumour suppressor genes is characterized by the presence of brain malformations, the
cortical tubers that are thought to contribute to the generation of pharmacoresistant epilepsy.
Here we report that tuberless heterozygote Tsc1þ / mice show functional upregulation of
cortical GluN2C-containing N-methyl-D-aspartate receptors (NMDARs) in an mTOR-
dependent manner and exhibit recurrent, unprovoked seizures during early postnatal life
(oP19). Seizures are generated intracortically in the granular layer of the neocortex. Slow
kinetics of aberrant GluN2C-mediated currents in spiny stellate cells promotes excessive
temporal integration of persistent NMDAR-mediated recurrent excitation and seizure
generation. Accordingly, specific GluN2C/D antagonists block seizures in Tsc1þ / mice
in vivo and in vitro. Likewise, GluN2C expression is upregulated in TSC human surgical
resections, and a GluN2C/D antagonist reduces paroxysmal hyperexcitability. Thus, GluN2C
receptor constitutes a promising molecular target to treat epilepsy in TSC patients.
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T
uberous sclerosis complex (TSC) is an autosomal-
dominant disease affecting multiple organ systems (brain,
skin, kidney, heart and lung) and caused by germline
mutations in one of the tumour suppressor genes, TSC1 or TSC2
(ref. 1). Inactivation of either of these genes leads to
hyperactivation of the mammalian target of rapamycin (mTOR)
pathway and promotes neuropathological abnormalities
associated with TSC2–4. The most devastating clinical and
pathological expressions of TSC involves the central nervous
system, and includes malformative brain lesions, the cortical
tubers, epilepsy, autism, cognitive impairment and glial tumours5.
Epilepsy begins in infancy and is difficult to treat with 85–90%
patients remaining with pharmacoresistant seizures5.
The molecular mechanisms governing epileptogenesis in TSC
and the contribution of tuber formation have been intensively
studied during the last decade and were subjects of intensive
debates. Recent evidence indicates that gliomas are formed by
biallelic TSC1 or TSC2 gene inactivation, reflecting a double-hit
mechanism according to which a germline or a somatic mutation
(likely occurring during development) affects the non-mutated
allele, producing ‘loss of heterozygosity’6. However, loss of
heterozygosity at either TSC gene is a rare event in tubers in
human7, and although it may affect selected population of giant
cells within cortical tubers, most of the cells in whole tuber
sections have heterozygote mutations8.
Although correlations have been found between severity of the
condition and the number of tubers9,10, and between topography
of cortical tubers and type of epilepsy, it remains elusive whether
tubers are intrinsically epileptogenic as some patients with
numerous tubers have a benign condition, whereas some
others, without tubers, have extremely severe epilepsy11–14.
Furthermore, the epileptogenic zone may not be exactly
superimposed to the lesion and includes some adjacent or,
more rarely, remote areas12. This could explain why for
approximately one-third of individuals who undergo epilepsy
surgery, seizures persist after removal of the cortical tubers
suspected to be epileptogenic9,10. Thus, it is not clear what
mechanisms underlie epilepsy in perituberal region and in
patients without evidence of cortical tubers or other dysgenetic
features.
Numerous animal models of TSC have been generated in order
to evaluate the mechanisms by which TSC genes loss results in the
diverse pathological phenotypes. Mouse models generated using
different brain-specific promoters and conditional alleles, in
which both alleles of either Tsc1 or Tsc2 are lost in neurons or
glia, display a severe neurological phenotype including morpho-
logical and clinical TSC features such as tuber-like structures,
failure to thrive, frequent seizures and early mortality15–18.
However, both heterozygous Tsc1 and Tsc2 knockout mice
demonstrate behavioural and electrophysiological abnormalities
and cognitive dysfunction in the absence of tubers or
seizures4,19,20. This supports the concept that haploinsufficiency
of Tsc1 or Tsc2 expression contributes significantly to the brain
manifestations of TSC, although epileptic phenotype has not been
reported so far for these mice.
Possible mechanisms of seizure generation in TSC could
include changes in excitatory and inhibitory neurotransmitter
function that may lead to abnormal neuronal synchronization
and imbalance between excitation and inhibition21,22. Several
reports have shown an increased expression of excitatory amino-
acid binding sites in the epileptic cortex and altered ionotropic
glutamate receptors expression patterns in human cortical
tubers23–26. N-methyl-D-aspartate receptors (NMDARs) are
putative candidates to explain the hyperexcitability of TSC
neuronal networks. Slow decay kinetics of the currents
mediated by NMDARs could facilitate synchronization in
neuronal networks and thus exert proepileptic effects. However,
the functional and proepileptic significance of NMDARs in
epileptogenesis associated with TSC has not been explored.
In this study, we report that heterozygote Tsc1þ / mice show
functional upregulation of cortical GluN2C-containing NMDARs
and exhibit spontaneous seizures associated with clinical
manifestations during early postnatal life (oP19) despite the
absence of major morphological changes in the brain15,20.
Selective inhibition of these receptors strongly disrupts
spontaneous epileptiform activity in Tsc1þ / mice.
Furthermore, electrophysiological and quantitative real-time
reverse transcription polymerase chain reaction (RT-PCR)
analysis of postsurgical tissue from TSC patients reveal
upregulation of GluN2C subunits, indicating that these
NMDAR subunits are instrumental in human TSC. Collectively,
these observations suggest that an upregulation of GluN2C
subunits is of paramount importance in the manifestation of
epileptic phenotypes associated with TSC.
Results
Spontaneous seizures in Tsc1þ / mice. To characterize func-
tional abnormalities of haploinsufficient Tsc1þ / mice, lacking
major malformations15,20, in vivo intracortical electroencephalo-
graphy (EEG) recordings in somatosensory S1 cortex of head-
restrained non-anaesthetized Tsc1þ / mice at postnatal days
P9–P33 were performed. Spontaneous recurrent seizures
occurred in 77% of Tsc1þ / mice tested at P9–P18 (26 out of
34), but were not observed in Tsc1wt mice of the same age (Fig. 1
and Supplementary Figs 1 and 2). The seizures started 2–3 h after
onset of EEG recordings and recurred as often as six per hour.
Ictal discharges were often associated with screaming, oro-facial
automatisms, head tremor, straub tail and tonic-clonic seizures
(Supplementary Movie 1), followed by a quiet behaviour
(Supplementary Movie 2).
Ictal EEG patterns started as high-frequency, low-amplitude
activity that progressively evolved to high-amplitude regular
polyspike trains involving all cortical layers. Subsequently, there
were disruptions of the discharges with a reduction in EEG
amplitude in cortex and appearance of high-amplitude rhythmic
spike-wave trains in the hippocampus (Fig. 1a,b). Wavelet
analysis showed an increase in high-frequency activity during
ictal discharges (Fig. 1c). The contributions of d, g and fast ripple
bands in power spectrum during discharges were significantly
larger in neocortical layer 4 (L4) compared with layer 2/3 (L2/3;
Fig. 1d, bottom panels). The amplitude and duration of
discharges varied within litters with a mean amplitude of
615±18 mV and a mean duration of 70.3±5 s, (n¼ 104 seizures;
N¼ 20 mice; Fig. 1d, upper panels). Interestingly, epileptic
phenotype was not observed in Tsc1þ / mice at ages older than
P19 (P19–P33, N¼ 10), indicating that this is a developmental
insult.
The seizure onset as well as the peaks of averaged population
spikes in L4 preceded those in L2/3 (Supplementary Fig. 3a, mean
delay for the peaks was 8.0±1.3ms, N¼ 11 mice). These
observations and current source density (CSD) analysis suggest
that epileptic activities in the cortex are initiated in granular
cortical layer before spreading to supra- and infragranular layers
(Supplementary Fig. 3b).
Qualitatively, similar results were obtained in coronal slices
of Tsc1þ / mouse brains, where intralaminar circuitry and
horizontal recurrent connections were intact, but thalamo–
cortical inputs were absent. In simultaneous whole-cell recordings
from somatosensory cortical excitatory neurons in L4 and L2/3
spontaneous synchronized bursts were observed first in L4 and
subsequently in L2/3 neurons with an average delay of
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30.4±5.5ms (61 synchronous bursts were analysed; Fig. 2a,b).
Therefore, L4 neurons have a central role in neocortical
epileptogenesis in Tsc1þ / mice.
Upregulation of GluN2B and GluN2C/D NMDARs in Tsc1þ /
mice. L4 is the main collector of sensory information and
cortical ‘hub’ for intracolumnal information processing27.
Recurrent activity triggered within the highly interconnected
networks of L4 has been suggested to act to selectively amplify
and redistribute transient high-frequency thalamo–cortical
inputs28,29. What are the mechanisms underlying the increased
integrative capacity of L4 neurons in Tsc1þ / mice? As
NMDARs have an important role in L4 neuron integrative
properties30,31, we next examined whether slow NMDAR-
mediated signalling was altered in Tsc1þ / mice.
The L4–L4 connections are almost the only intracortical
synaptic input that L4 spiny stellate cells (SSCs) receive32. This
allows an estimation of the contribution of the slow NMDA
component in isolated L4–L4 connections by measuring
spontaneous activity from SSCs. To monitor the NMDAR-
mediated current, we performed whole-cell recordings of
spontaneous excitatory postsynaptic currents (sEPSCs) from L4
SSCs (Fig. 3a) and L2/3 pyramidal neurons (PNs) in coronal
brain slices from Tsc1þ / mice (P14–P16) in voltage-clamp
mode at  50mV. The decay kinetics of the composite sEPSCs
was significantly slower in Tsc1þ / than that in Tsc1wt mice
both in L2/3 and L4 neurons (Fig. 3b,c), suggesting an increased
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Figure 1 | Spontaneous seizures in Tsc1þ / mice. (a) Intracortical EEG recorded using a 16-channel silicone probe in a head-restrained P16 Tsc1þ /
mouse. The upper channel corresponds to the superficial intracortical electrode placed at 100 mm from the pia. Shown are epileptic discharges recorded at
the depths indicated on the left of each trace. (b) Superimposed epileptic discharges in L4 of neocortex (red) and hippocampus (black). (c) Wavelet
analysis during the ictal events for traces shown in b. Upper panel: neocortex, lower panel: hippocampus. (d) Cumulative probabilities of seizures maximal
amplitudes for L2/3 and L4 (upper left, n¼ 84 seizures, N¼ 20 mice) and durations (upper right, n¼ 104 seizures, N¼ 20). Seizure durations were
the same for all layers, data for L2/3 are shown. Bottom: relative integral power of d-(1–4Hz), y-(4–8Hz), a-(8–12Hz), b-(12–25Hz), g-(25–100Hz)
and fast ripple (FR; 100–500Hz) band components of EEG in L2/3 (n¼ 31 seizures, N¼ 20) and L4 (n¼ 29 seizures, N¼ 20) revealed by Fourier
transform analysis. All means±s.e.m.; *Po0.05, **Po0.01, ***Po0.001, two-sample two-tailed t-test.
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contribution of NMDAR-mediated current and an upregulation
of GluN2B, and/or GluN2C and GluN2D NMDAR subunits
endowed with slow decay kinetics33. To quantify alterations in
sEPSCs decay, we measured charge transfer normalized by the
peak amplitude (see Methods section for details). In Tsc1þ /
mice, normalized charges of sEPSC were 1.5±0.1 in L2/3 and
2.55±0.16 in L4 of those in Tsc1wt mice (L2/3: n¼ 27 and 16
neurons; L4: n¼ 34 and 29 neurons for Tsc1þ / and Tsc1wt
mice, respectively; two-sample, two-tailed t-test Tsc1wt versus
Tsc1þ / in L2/3 Po5 10 4, and in L4 Po1 10 11).
Bi-exponential-weighted time constants of sEPSC decay (tw) were
in Tsc1wt mice 7.5±0.6ms for L2/3 and 7.4±0.4ms for L4, and
in Tsc1þ / mice 13.28±0.97ms for L2/3 and 16.76±1.19ms
for L4 (two-sample, two-tailed t-test Tsc1wt versus Tsc1þ / in
L2/3 Po2 10 4, and in L4 Po8 10 9). Corresponding
amplitudes of sEPSC in Tsc1þ / mice were not significantly
different from those in Tsc1wt mice in L4 (two-sample, two-tailed
t-test, P40.7), however, they were slightly increased in L2/3
(two-sample, two-tailed t-test, Po0.07; Supplementary Fig. 4).
To directly determine the involvement of NMDAR subtypes in
prolongation of sEPSCs, we used specific GluN2B (Ro25-6981)
and GluN2C/D (UBP141 (ref. 34), and DQP1105 (ref. 35))
antagonists (Supplementary Table 1). In L4 SSCs in Tsc1þ /
mice UBP141 and DQP1105, but not Ro25-6981, accelerated
sEPSCs decay, restoring it to the values in Tsc1wt mice (Fig. 3d,f,i
and Supplementary Table 2), suggesting an increased con-
tribution of GluN2C/D but not GluN2B subunits. In Tsc1þ /
mice, the normalized charge of sEPSC in L4 in the presence of
UBP141 (10 mM) was 0.61±0.07 (n¼ 10, Po4 10 4, paired
two-tailed t-test) and in the presence of DQP1105 (10 mM) was
0.48±0.04 (n¼ 12, Po2 10 7, paired two-tailed t-test) of that
without drugs. Relative tw values were 0.56±0.06 for UBP141
(Po5 10 5, paired two-tailed t-test) and 0.41±0.04 for
DQP1105 (Po3 10 8, paired two-tailed t-test), respectively,
of those without drugs. In Tsc1wt mice, sEPSCs decay kinetics was
not affected by either drug (the normalized charge values were
similar in the presence and absence of the drugs: 1.03±0.13,
n¼ 9, P40.75 for UBP141 and 1.06±0.07, n¼ 12, P40.4 for
DQP1105; paired two-tailed t-test). Correspondingly, the relative
tw values were 0.98±0.07, P40.3 for UBP141 and 1.07±0.07,
P40.7 for DQP1105 (paired two-tailed t-test). Corresponding
amplitudes of sEPSC for all sets were not significantly different
(analysis of variance (ANOVA), P40.9; Supplementary Fig. 4).
In addition, we performed recordings of miniature EPSCs
(mEPSCs) in L4 cells in the presence of tetrodotoxin (1 mM).
Similarly to sEPSCs, the average decay kinetics of the late
component in composite mEPSCs was significantly slower in
Tsc1þ / than that in Tsc1wt mice (Supplementary Fig. 5). Thus,
in Tsc1þ / mice, averaged normalized charge of mEPSC in L4
was 2.58±0.18 of that in Tsc1wt mice (n¼ 10 and 9 neurons, for
Tsc1þ / and Tsc1wt mice, respectively; two-sample, two-tailed
t-test Tsc1wt versus Tsc1þ / Po5 10 7). In Tsc1þ / mice,
the normalized charge of mEPSC and tw in L4 in the presence of
DQP1105 (10 mM) were 0.45±0.07 (n¼ 8, Po1.7 10 4,
paired two-tailed t-test) and 0.55±0.03 (n¼ 9, Po3.2 10 5,
paired two-tailed t-test), respectively of those without drugs.
In Tsc1wt mice, mEPSCs decay kinetics were not affected by
DQP1105: the normalized charge and tw in the presence of
DQP1105 were 0.96±0.14 (n¼ 7, P40.75, paired two-tailed
t-test) and 1.13±0.13 (n¼ 8, P40.48, paired two-tailed t-test),
respectively, of those without drug. Corresponding amplitudes of
mEPSC for all sets were not significantly different (ANOVA,
P40.9; Supplementary Fig. 5).
In contrast to the data in L4, the contribution of both GluN2B
and GluN2C/D subunits was increased in L2/3 of Tsc1þ / mice.
Both Ro25-6981 and UBP141 accelerated sEPSC decay (Fig. 3e,h).
In the presence of 1mM Ro25-6981, the normalized sEPSC charge
in Tsc1þ / mice was 0.79±0.05 of control without Ro25-6981
(n¼ 9, Po0.005, paired two-tailed t-test). In Tsc1wt mice, this
value was 1.03±0.09 (n¼ 6, P40.75, paired two-tailed t-test).
Similarly, corresponding numbers for UBP141 in L2/3 were
0.8±0.07 of controls without the drug (n¼ 12, Po0.02, paired
two-tailed t-test) in Tsc1þ / mice and 1.02±0.07 (n¼ 9, P40.8,
paired two-tailed t-test) in Tsc1wt mice. However, the interpreta-
tion of UBP141 effects in L2/3 is complicated by the fact that at a
concentration of 10 mM it partially affects also GluN2B receptors
(Supplementary Table 1). The amplitudes of sEPSCs in the
presence of antagonists were not significantly different from
control values for all experimental sets (ANOVA, P40.15;
Supplementary Fig. 4).
Therefore, there is an increased contribution of GluN2C/D
subunits in L4, but of both GluN2B and GluN2C/D subunits in
L2/3 in Tsc1þ / mice when compared with naive Tsc1wt mice.
To determine whether upregulation of the GluN2C/D-
NMDAR component in L4 is a direct consequence of enhanced
mTOR signalling caused by Tsc1 inactivation, we performed
experiments in Tsc1þ / mice chronically treated with the
mTOR inhibitor rapamycin (see Methods section). Recordings of
sEPSC from SSCs in L4 in rapamycin-treated Tsc1þ / mice
(P14–P16) showed the absence of the UBP141-sensitive compo-
nent (Fig. 3d,g,j). In rapamycin-treated Tsc1þ / mice, the
normalized charge of sEPSCs in SSCs in the presence of UBP141
(10 mM) was 1.05±0.11 (n¼ 12, P40,6, paired two-tailed t-test)
of that without the drug. Furthermore, normalized charge of
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Figure 2 | Onset of spontaneous synchronous bursts in L4 preceded
that in L2/3. (a) Middle: traces of whole-cell currents recorded at
Vh¼  70mV simultaneously from two PNs in L2/3 and two SSCs in L4
(shown schematically on the left) in neocortical slices from Tsc1þ / mice.
Right: expanded traces of the same bursts marked by grey box are shown.
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bursts in L4 precede those in L2/3. (b) Distribution of the onset delays (Dt)
between bursts recorded simultaneously from L2/3 and L4 neurons (61
synchronous bursts were analysed, N¼4 mice). Dt was measured from
filtered (0.5 kHz) events at the level of the burst threshold (Thr) set at
40 pA as shown on the left. Events with amplitude o40pA were not
considered as the bursts. Fitting a Gaussian Function of Dt distribution
revealed at least two peaks with the most of the Dt values peaking at 12ms.
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Figure 3 | Layer-specific functional upregulation of GluN2B and GluN2C/D subunits containing NMDA receptors in Tsc1þ / mice. (a) Representative
traces of spontaneous activity recorded in whole-cell mode at holding potential  50mV from SSCs in L4 in neocortical coronal slices from Tsc1wt,
Tsc1þ / mice and in Tsc1þ / mice in the presence of UBP141 (10mM). (b) Grand averages of normalized (Norm.) and superimposed traces of
sEPSC recorded from PNs in L2/3 (left) or SSCs in L4 (right) in Tsc1wt and Tsc1þ / mice at  50mV. For each neuron, original traces from individual
experiments were aligned based on the starts of their rising phases and averaged. These averaged traces from individual experiments were normalized
and averaged to form grand average traces shown. Pooled data from 16 neurons for Tsc1wt (N¼ 5 mice) and 27 neurons for Tsc1þ / in L2/3 (N¼ 8)
and from 29 neurons for Tsc1wt (N¼ 6) and 34 neurons for Tsc1þ / in L4 (N¼ 10). (c) Summary data for normalized charges of sEPSC in L2/3 and
L4 in Tsc1wt and in Tsc1þ / mice (relative to Tsc1wt). (d) Left two panels: superimposed grand average of normalized traces of sEPSC recorded in
L4 in Tsc1wt and Tsc1þ / mice in control and in the presence of UBP141. Right two panels: superimposed grand average of normalized traces of
sEPSC recorded in L4 in Tsc1þ / and Tsc1wt mice pretreated with either vehicle or rapamycin. (e,h) Summary data for the effects of UBP141 and
Ro25-6981 (1mM) on normalized charges of sEPSC (e) and weighted time constant, tw (h) of sEPSC decay in L2/3 in Tsc1wt and in Tsc1þ / mice.
(f,i) Summary data for the effects of UBP141, DQP1105 (10 mM) and Ro25-6981 on normalized charges of sEPSC (f) and tw (i) in L4 in Tsc1wt and in
Tsc1þ / mice. (g,j) Summary data for the effects of UBP141 on normalized charges of sEPSC (g) and tW (j) in L4 in Tsc1wt and in Tsc1þ / mice
pretreated with either vehicle or rapamycin. All means±s.e.m. All data sets were analysed using one-way ANOVA followed by Fisher’s Least
Significant Difference (LSD) post hoc test (see Supplementary Table 2 for statistics); *Po0.05, **Po0.01, ***Po0.001. NS, not significant,.
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ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5563
6 NATURE COMMUNICATIONS | 5:4563 | DOI: 10.1038/ncomms5563 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
sEPSCs in rapamycin-treated Tsc1þ / mice was not significantly
different from that of vehicle-treated Tsc1wt mice (1.05±0.08 of
that in vehicle-treated Tsc1wt mice, n¼ 14 for Tsc1þ / , n¼ 10
for Tsc1wt, two-sample two-tailed t-test P40.75; Fig. 3g).
This finding indicates a crucial role of mTOR signalling in
functional upregulation of GluN2C/D-containing NMDARs in
Tsc1þ / mice.
Interestingly, in L4 fast-spiking (FS) interneurons neither
UBP141 nor Ro25-6981 altered sEPSCs decay in both Tsc1wt and
Tsc1þ / mice (Supplementary Fig. 6), suggesting that NMDAR-
mediated currents in inhibitory neurons remain intact.
To further determine the functional effects of UBP141 in
Tsc1þ / mice, we tested its actions on the amplitude and
frequency of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid receptor (AMPAR)-mediated sEPSCs. UBP141 altered
neither the amplitude nor the kinetics of AMPAR-mediated
sEPCS recorded at  80mV in L4 SSCs (Supplementary
Fig. 7a,b). The frequency of sEPSCs recorded at  80mV in L4
SSCs was not different from that in Tsc1wt mice. However, in L2/3
PNs it was significantly higher than that of Tsc1wt mice
(Supplementary Fig. 7c), and was reduced by bath application
of UBP141 in Tsc1þ / (Supplementary Fig. 7e), but not in
Tsc1wt (Supplementary Fig. 7d) mice. Therefore, in Tsc1þ /
mice L4 GluN2B/C/D channels presynaptic to L2/3 PN could
contribute to increase the activity of the latter.
mTOR-dependent upregulation of the slow NMDAR subunits
was confirmed by quantitative RT–PCR revealing 2.4-fold
elevation of GluN2C mRNAs (Po0.005, two-tailed t-test) in
the neocortex of Tsc1þ / mice (N¼ 5) compared with age-
matched Tsc1wt (N¼ 5) mice (Supplementary Fig. 8).
Thus, the contribution of GluN2C-containing NMDARs with
slow kinetics is increased in neocortical L4 and L2/3 excitatory
neurons in mice with haploinsufficient Tsc1 mutation. Similar
alterations in sEPSC kinetics were observed in ‘double-hit’ Tsc1
mutant mice. In a recent study, using in utero electroporation and
relying on the )second-hit* mutation concept36, Bordey and co-
workers15 generated a Tsc1 / animal model with the hallmark
of human TSC, namely the tubers. We used this model to test the
impact of a )second-hit* mutation on functional upregulation of
slow NMDARs. To do that, Tsc1flx/mut mice (as well as Tsc1flx/wt)
were injected in utero at embryonic day 16 (E16) with pCAG-
mRFP alone or combined with pCAG-Cre:GFP to induce, after
electroporation, deletion of the floxed Tsc1 gene in a subset of
neurons. The fluorescence of the monomeric red fluorescent
protein (mRFP) plasmid allows identification of electroporated
neurons and green fluorescent protein (GFP) for detection of
neurons containing pCAG-Cre. Whole-cell recordings in
neocortical slices from mRFPþ /GFPþ neurons of Tsc1flx/mut;
pCAG-Cre and Tsc1flx/wt; pCAG-Cre conditional knockout mice
(hereafter referred to as Tsc1null and Tsc1haplo neurons,
respectively) at  50mV revealed enhanced contribution of
slow UBP141-sensitive NMDAR-mediated components in sEPSC
compared with those from control mRFPþ neurons of Tsc1flx/wt
mice, in the same manner as in non-electroporated heterozygote
Tsc1þ / mice. Therefore, GluN2C/D-mediated currents are
present in both Tsc1haplo and )double-hit* Tsc1null neurons.
Importantly, the extent of slow NMDARs contribution was the
same for the electroporated neurons with heterozygote and
homozygote Tsc1 mutations (Supplementary Fig. 9).
Slow NMDAR-mediated signal determines temporal integration.
To test temporal summation at g-band frequency, we performed
simultaneous whole-cell recordings from pairs of synaptically
coupled SSCs in L4 of somatosensory cortex in slices
from Tsc1þ / and Tsc1wt P14–P16 mice. The majority of
interconnected excitatory neurons were SSCs with an asymme-
trical dendritic arborization largely confined to L4 and char-
acteristics action potentials firing pattern (Fig. 4a,b). In
concordance with the slower NMDAR-mediated component of
synaptic transmission in Tsc1þ / mice, recordings revealed a
significantly higher extent of temporal integration compared with
Tsc1wt mice when measuring EPSCs evoked by stimulation of
presynaptic cells with a train of action potentials. Normalized
charge transfer of the train-EPSCs estimated from normalized by
the amplitude of the first peak currents was 0.093±0.004 s in
Tsc1þ / (n¼ 5) and 0.050±0.006 s (n¼ 7) in Tsc1wt mice,
respectively, (Po0.0005, two-tailed t-test; Fig. 4c–e). Further-
more, recordings in Tsc1þ / mice demonstrated significantly
increased contribution of UBP141-sensitive NMDAR-mediated
train-EPSCs to the postsynaptic summation of EPSCs but not in
Tsc1wt mice (Fig. 4d,f,g). In the presence of UBP141, the
normalized sEPSC charge in Tsc1þ / mice was 0.57±0.11 of
that without UBP141 (n¼ 4, Po0.03, paired two-tailed t-test). In
Tsc1wt mice, this value was 1.06±0.07 (n¼ 6, P40.44, paired
two-tailed t-test). Thus, abnormal slowing of the NMDAR-
mediated current kinetics increases temporal integration within
recurrent network in L4 of Tsc1þ / mice.
GluN2C/D antagonists reduce epileptogenecity in Tsc1þ /
mice. The critical role of L4 neurons in increased temporal
integration and seizure generation suggests that the selective
blockade of long-lasting GluN2C/D subunits containing
NMDAR-mediated currents may have antiepileptic effects. To
test this possibility, we first used microelectrode array extra-
cellular recordings in acute coronal neocortical slices taken from
P15 Tsc1þ / mice. Spontaneous discharges lasting for up to 10 s
were recorded in L2/3 and L4. UBP141 (10 mM) selectively
reduced the amount of long-lasting epileptiform episodes, with-
out altering the number of interictal bursts (durationr500ms;
Supplementary Fig. 10).
We next tested the antiepileptic actions of UBP141 and
DQP1105 in vivo by intraperitoneal (i.p.) injections of the drugs
(75 and 28mg kg 1, respectively) to Tsc1þ / mice. These values
were the lowest effective doses identified by testing increasing
doses of these compounds (see Methods section for details). In
three of six mice tested, the seizures were completely stopped
B40min after i.p. injection of UBP141, and in the remaining
mice (n¼ 3) there was a seizure-free period lasting 109±39min
(Fig. 5a,b). I.p. injection of DQP1105 stopped seizures on average
for 72.6±5.5min in four out of six mice, and seizures were
completely stopped in two mice (Fig. 5c). In contrast, recurrent
epileptic discharges persisted up to 7 h in Tsc1þ / mice that did
not receive the antagonists or were i.p. injected with vehicle
(Fig. 5d,e). Therefore, selective antagonists of GluN2C/D-
containing receptors have in vivo and in vitro antiepileptic
actions in Tsc1þ / mice.
Importantly, after UBP141 injection a basal activity remained
unaltered, in particular, at g-frequency band (Supplementary
Fig. 11), known to be enhanced by common NMDAR
antagonists37. This might indicate that used dosage of UBP141
corresponds to the concentration in the brain to be within the
selectivity range for GluN2C/D. The used dosage of DQP1105
(28mg kg 1) according to in silico prediction tools appears to be
also within the selectivity range for GluN2C/D receptors (see
Methods section for details and Supplementary Table 1). The
direct assessment of the distribution of both drugs in the brain
requires further studies.
Collectively, our observations on the Tsc1þ / animal model
suggest that seizures are generated intracortically owing to an
upregulation of GluN2C receptors in recurrent connections
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between SSCs in the granular layer of neocortex and then
propagate to other layers. Interestingly, in some Tsc1þ / mice
sensory stimulation (mainly back and feet corresponding to
receptive field in the recorded cortical zone) induced a seizure
(Supplementary Fig. 12), indicating that sensory inputs to L4 may
trigger paroxysmal recurrent network activity in the cortex. This
strongly reinforces the importance of the hyper-synchronizing
effects of L4 and of functional upregulation of GluN2C subunits
of NMDARs.
GluN2C overexpression in human TSC postsurgical tissue.
To test whether findings obtained in the animal model can be
translated to human patients with TSC, we performed studies in
human postsurgical tissue. Quantitative RT–PCR performed in
human samples with TSC2 mutation (age at surgery ranged from
8 to 16 months; Supplementary Table 3) revealed a 20-fold
increase of GluN2C mRNA compared with fetal control brains
(Fig. 6a; Po0.001, two-tailed t-test) and more than 2.5-fold
increase compared with adult control brains.
Whole-cell patch-clamp recordings in brain slices from the
human TSC specimens showed that sEPSCs recorded from
dysplastic neurons in granular and supragranular layers (Fig. 6b)
were significantly reduced and curtailed by UBP141 (Fig. 6c,d).
The amplitude, total and normalized charges of sEPSC in the
presence of UBP141 (10 mM) were 0.78±0.04 (Po0.002, paired
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Figure 5 | Acute antiepileptic effect of i.p. administration of UBP141 or DQP1105 in vivo. (a) Intracortical EEG recordings in head-restrained P15
Tsc1þ / mouse before and after i.p. administration of UBP141 (75mg kg 1; indicated by arrow). The upper trace corresponds to the superficial
intracortical electrode placed at 100 mM from the pia, channels are separated by 200 mm. (b–e) Time course of spontaneous seizure activity in Tsc1þ /
mice at P14–P16 before and after i.p. administration of UBP141 (N¼ 6 mice; b), DQP1105 (28mg kg 1, N¼6; c), vehicle control (N¼ 3; d) and
control without any treatment (N¼ 3; e). Individual seizures are represented by black squares. Each row (#) represents individual experiment.
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two-tailed t-test, n¼ 7), 0.59±0.08 (Po0.002, paired two-tailed
t-test, n¼ 7) and 0.68±0.09 (Po0.01, paired two-tailed t-test,
n¼ 7), respectively, of controls. The values of tw of sEPSC
decay in TSC samples were 16.6±2.1ms without UBP141
and 8.69±0.71ms in the presence of UBP141 (Po0.0002,
two-samples two-tailed t-test, n¼ 7).
Furthermore, in two human tissue samples displaying
spontaneous paroxysmal activity UBP141 (10 mM) reduced
spontaneous spike frequency (Supplementary Fig. 13). Therefore,
in conjunction with animal model data functional upregulation of
GluN2C may contribute to epilepsy associated with TSC in
human patients.
Genetic polymorphisms and biochemical markers of mTOR
activation have been also identified in patients with isolated focal
cortical dysplasia (FCD), a common aetiology of intractable
epilepsy38–42. GluN2B and GluN2C mRNA levels have been
found to be upregulated in dysplastic neurons microdissected
from human FCD specimens obtained during epilepsy surgery26.
Therefore, we tested whether slow UBP141-sensitive NMDAR-
mediated component is present in dysplastic neurons from
patients with FCD. Whole-cell patch-clamp recordings were
performed in five human samples (age at surgery ranged from 1
to 14 years; Supplementary Table 4). As in the TSC case, sEPSCs
recorded from dysplastic neurons in granular and supragranular
layers (Fig. 7a) were significantly curtailed by UBP141 (Fig. 7b,c).
The tw values of sEPSC decay were 22.7±2.9ms in control
(n¼ 17) and 9.9±0.7ms in the presence of UBP141 (n¼ 13,
Po0.001, two-sample, two-tailed t-test). The total and
normalized charge of sEPSC in the presence of UBP141
(10 mM) were 0.56±0.08 (Po0.0003, paired t-test, n¼ 12) and
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Figure 6 | Upregulation of GluN2C subunit of NMDARs in human postsurgical tissue of TSC patients. (a) Differential expression of NMDA receptor
subunits in human brain tissue from normal individuals and TSC patients. Left panel: quantitative RT-PCR showing the relative expression of mRNAs
encoding different NMDAR subunits in normal samples from human fetal (pool of 59 male/female Caucasian fetuses ages 20–33 weeks) and adult (pool of
10 male/female Caucasians ages 20–68 years) cerebral cortex. The error bars indicate±s.e.m. from two replicates of quantitative RT-PCR experiments for
both sets. b-actin and GAPDH were used for normalization. Right panel: fold change expressions for each receptor in two TSC patients calculated relative to
the normal fetal brain. The error bars for patient 1 indicate the±s.e.m. from two replicates of quantitative RT-PCR experiments. The error bars for patient
2 indicate the ±s.e.m. from three samples. All samples were tested in duplicate. (b) Morphology of dysplastic excitatory neurons in cortical slices of
human postsurgical tissue of TSC patients. Scale bar, 50mm applies to both images. (c) Grand averages of normalized (Norm.) and superimposed traces of
sEPSC recorded at  50mV from dysplastic neurons in cortical slices of human postsurgical tissue of three TSC patients in control (pooled data from eight
neurons) and in the presence of 10mM UBP141 (pooled data from seven neurons). (d) Summary data for the effects of 10mM UBP141 on amplitudes,
normalized and total charges of the sEPSC recorded from human postsurgical tissue (relative to corresponding controls, n¼ 7 cells). All means±s.e.m.,
*Po0.05, **Po0.01; paired two-tailed t-tests.
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0.59±0.06 (Po2 10 5, paired two-tailed-test, n¼ 12) of
controls, respectively. Amplitudes of sEPSC in the presence of
antagonists were not significantly different from control:
0.88±0.07 of control (P40.16, two-tailed t-test; Fig. 7d).
Thus, although our direct results are designed for studying
the mechanisms of epileptogenesis associated with TSC1 muta-
tion, they may provide important link for other neurodevelop-
mental disorders with epilepsy associated with mTOR activation
such as FCD.
Discussion
Our observations provide the first evidence that GluN2C
NMDARs are functionally upregulated in neurons of hetero-
zygote Tsc1þ / mice and in human TSC patients. The
upregulated expression of GluN2C receptors in neocortical L4
appear as prerequisite for seizure generation in the developing
haploinsufficient Tsc1þ / mice despite the absence of tubers and
are key factors in the mechanisms of intracortical epileptogenesis.
In line with this concept, GluN2C/D receptor antagonists stop
seizures in vivo and in vitro. Our data with rapamycin-treated
mice indicate a crucial role of mTOR signalling in increased
functional expression of GluN2C NMDARs in Tsc1þ / mice.
Finally, examination of postsurgical tissue samples from TSC
patients revealed that these findings could be potentially
translated to human. Overall, our data suggest that GluN2C-
subunit targeted therapy provides a promising novel therapeutic
avenue to treat epilepsy associated with TSC.
Our in vivo recordings show that Tsc1þ / mice exhibit a
variety of seizure types (most often generalized, up to 7min
duration). Fast Fourier transform power spectra analysis of the
EEG recordings revealed increased contribution of fast and
ultrafast (200–500Hz) oscillations—an important hallmark of
epileptiform activity. EEG patterns in Tsc1þ / mice resemble
those seen in human epileptic seizures, and are typically
associated with remarkable behavioural phenotype: freezing,
facial automatisms, head tremor, straub tail and tonic-clonic
seizures. Seizures in this animal model, therefore, entirely fulfil
the criteria and definition of epileptic seizures proposed by the
International League Against Epilepsy and the International
Bureau for Epilepsy43.
However, some features and clinical phenotype in this animal
model are distinctive from the human disease: in particular in
mice seizures spontaneously disappear after P19, whereas in
children with TSC seizures are usually highly persistent, although
seizure type may change with age.
Both Tsc1 and Tsc2 heterozygous knockout mice have been
intensively studied in the last years. Tsc1þ / and Tsc2þ / mice
show social and cognitive deficits in the absence of any apparent
major cerebral pathology4,19,20, although loss of a single copy of
Tsc gene is sufficient to perturb neuronal morphology, dendritic
spine structure22 and axon guidance44. Eventually, it has been
proposed as a model in which haploinsufficiency for the Tsc genes
leads to aberration in neuronal functioning, including changes in
synaptic strength and glutamate receptor composition of
excitatory synapses, resulting in impaired learning and social
behaviour. Importantly, the mTOR complex 1 (mTORC1)
inhibitor rapamycin improves learning and memory deficits
in Tsc2þ / mice4, and social deficit in both Tsc1þ / and
Tsc2þ / mice, suggesting that uncontrolled mTORC1 signalling
is a core molecular mechanism involved in the behavioural
abnormalities19,45.
Thus, although mice haploinsufficient for the Tsc genes have
been utilized as models of autism4,19,20, occurrence of
spontaneous seizures in Tsc1þ / and Tsc2þ / rodents have
not been reported previously46. It is possible that early
spontaneous epileptic activity in Tsc1þ / heterozygous
knockout mice has been overlooked because of the strictly
limited age window (oP19) found in our study. Interestingly, in
82.1% of epileptic TSC patients, the epilepsy begins before 3 years
of life47. Thus, this early seizure appearance in Tsc1þ / mice is
consistent with the early epilepsy onset in TSC patients.
Spontaneous seizure discharges in Tsc1þ / mice involve
neocortical L4 before supra- and infragranular layers, both in vivo
and in vitro, indicating layer L4 as a possible origin of seizure
generation. L4 is the main acceptor of sensory inputs in which
SSCs act as effective integrators of powerful and persistent
NMDAR-mediated recurrent excitation29,31. On the other hand,
L4 neurons provide synaptic outputs to virtually all layers
in a cortical column (for review, see ref. 27). We suggest that in
Tsc1þ / mice, L4 SSCs with functionally upregulated GluN2C
receptors become effective ‘hyperintegrators’ of powerful
recurrent excitation and intracortical epileptic generator. It has
been hypothesized that normal brain circuits provide a template
that epileptic brain uses to generate seizures48, and in particular
that circuits responsible for generating seizure activity are
comparable to the circuits that generate spindle bursts49.
The rhythmic spike-wave discharge has been referred to as a
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Figure 7 | Functional upregulation of GluN2C/D subunits of NMDARs in
pediatric epilepsy surgery patients with focal cortical dysplasia (FCD).
(a) Morphology of dysplastic excitatory neuron in cortical slice of human
postsurgical tissue of a patient with FCD. Scale bar, 50mm. (b) Grand
average traces of sEPSC recorded at  50mV from dysplastic neurons in
cortical slices of human postsurgical tissue of five patients with FCD in the
absence (red, pooled data from 17 neurons) and in the presence of 10mM
UBP141 (blue, pooled data from 12 neurons). (Green trace)—UBP141-
sensitive sEPSC component revealed by subtraction of the trace with
UBP141 from the trace without UBP141. (c) Grand average traces of sEPSCs
normalized (Norm.) by peak amplitudes. (d) Summary data for the effects
of 10mM UBP141 on amplitudes, normalized and total charges of the sEPSC
recorded from human postsurgical tissue relative to corresponding controls.
All means±s.e.m., **Po0.01, ***Po0.001.Two-sample t-tests were
performed on the pooled data for each parameter (control conditions:
n¼ 17 cells, with UBP141: n¼ 12 cells). NS, not significant.
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perversion of the spindle oscillation50 with the circuits within
the cortex amplifying the spindle activity. This hypothesis was
derived primarily from CSD analysis of cortical region during
spindle activity51, showing that early significant current sink
occurs in cortical L4. This is in line with our own observations.
Intriguingly, tactile stimulation of the Tsc1þ / mouse back
induced prominent seizures (Supplementary Fig. 12), indicating
that seizure initiation can be triggered by conventional sensory
inputs to L4.
Extensive recurrent connectivity due to upregulated GluN2C
receptors in granular layer provide a source of powerful local
excitation and is capable of producing activity that is self-
generated and long-lasting. Rhythmic activity in the EEG g-band
is a near-ubiquitous feature of ongoing cortical activity and
responses to sensory input, and this activity has been found
selectively enhanced in epilepsy52. Combined computational and
experimental approaches show that high-frequency g rhythms
originate particularly from L4 (ref. 53). Our data show that slow
decay of the GluN2C-mediated current contributes more
efficiently to temporal summation at high-frequency activity.
Indeed, direct paired recordings of recurrent connections between
SSCs in L4 revealed increased temporal integration of excitatory
input in Tsc1þ / mice at g-band frequency synaptic input. As a
result neurons become more depolarized for a longer time
window promoting neuronal hypersynchronization within L4. In
concordance with patch-clamp data, i.p. injection of GluN2C/D
antagonists stopped recurrent seizures in Tsc1þ / mice in vivo.
Intriguingly, the impact of )second-hit* mutation on func-
tional upregulation of slow NMDARs in neurons was negligible.
Precisely, controlling the timing and location of Cre expression,
we could compare the cell-autonomous effects of loss of Tsc1 in
an otherwise unperturbed circuit or loss of both alleles in
heterozygous background in contrast to the mouse models where
Tsc1 is deleted in all forebrain neurons. The results showed that
extent of slow NMDAR receptor contribution was the same
irrespectively whether neurons were heterozygote or homozygote
for the Tsc1mutation. This indicates that monoallelic mutation in
the Tsc1 gene is sufficient to increase the functional expression of
GluN2C receptors.
Altered expression NMDAR mRNA has been reported for both
human TSC and FCD24,26. In particular increased levels of
GluN2B and GluN2D subunits mRNA were observed in tubers24.
These data differ from present data where selective upregulation
of GluN2C was observed. This discrepancy might be attributed to
the difference in methods used and different age group of
patients: 1-year-old patients in our study and 4–46-year-old (on
average 19.5±6 years) patients in ref. 24. However, selective
upregulation of GluN2C-subunit mRNA in single microdissected
dysplastic neurons (shown in ref. 24) is in a good agreement with
functional upregulation of GluN2C/D subunits shown by our
electrophysiological data in individual dysplastic neurons.
Importantly, sEPSCs recorded from dysplastic neurons brain
slices resected from patients with TSC and FCD were significantly
attenuated and curtailed by GluN2C/D antagonists. Thus, given
an increased expression of specific NMDAR subunits found in
tissue resected from patients with various types of drug-resistant
epilepsy25,26,54,55, the proposed mechanisms of intracortical
epileptogenesis and NMDAR-subunit targeted therapy may be
further extended to other types of epilepsy, including FCD, the
most frequent congenital lesions causing epilepsy.
It should be noted, however, that studies on postsurgery
samples from TSC and FCD patients need to be interpreted with
some caution. This includes our comparative findings from
paediatric tissue from TSC patients (B1-year old) with normal
fetal tissue. Non-epileptic normal age-matched control tissue is
not available for this human study owing to ethical issues, while
comparison with age-matched epileptic tissue with different
aetiology may lead to misinterpretation and wrong conclusions.
Our results should be replicated in other clinical studies with
larger cohorts and rigorous age correlation analysis.
The failure of general NMDAR antagonists to treat epilepsy in
preclinical studies56 may result from the need to restrict the
NMDARs blockade to the specific subunits involved in
epileptogenesis in TSC leaving intact pro-survival GluN2A-
mediated signalling involved in normal development, plasticity,
learning and memory57. Administration of non-specific NMDAR
antagonists alters g rhythms and can induce cognitive as well
as psychosis-like symptoms in humans58. In FS parvalbumin-
positive interneurons, NMDARs have a critical role for expression
of normal g rhythms and specific cognitive behaviours59. The
disruption of NMDAR signalling specifically in parvalbumin-
positive interneurons may lead to neural network dysfunction
that could underlie these symptoms. The NMDARs present in FS
interneurons, both in Tsc1wt and Tsc1þ / mice, were not
affected by selective GluN2B or GluN2C/D antagonists in our
experiments. This suggests that treatment with these compounds
does not alter inhibition provided by FS interneurons.
Furthermore, power of g oscillations of basal activity recorded
in Tsc1þ / mice in vivo was not affected by UBP141.
Abnormal signalling in the mTOR pathway is known to be
critical for the pathophysiology of epilepsy and other neurological
features of TSC, and other focal cortical malformations. In animal
models of TSC and cortical dysplasia, hyperactivation of the
mTOR pathway promotes epileptogenesis and neuropathological
abnormalities, and the mTOR inhibitor, rapamycin, prevents
epilepsy and associated cellular and molecular phenotypes2–4,60.
Altered mTOR pathway signalling was found in TSC,
FCD, hemimegalencephaly and ganglioglioma brain tissue
specimens38,40,61–63. The term ‘TORopathies’ was recently
coined to define a continuum of neurological disorders
characterized by altered cortical architecture, abnormal
neuronal morphology and intractable seizures as a consequence
of abnormal mTOR signalling63,64. There is strong evidence
supporting a role for mTORC1 in regulating the translation of a
number of proteins necessary for synaptic plasticity65, and there
is a possibility that mTORC1 also regulates translation of
GluN2C. Our findings obtained from TSC animal model may,
therefore, also have implications for other conditions in which
mTORC1 is hyperactive, ranging from Fragile X syndrome to
autism spectrum disorders66.
Methods
Animals. Breeding and experimental procedures were carried out in accordance
with European guidelines for animal research and in accordance with Institut
National de la Sante´ et de la Recherche Medicale guidelines for animal care in
research, and were approved by the local ethics committee (Comite´ d’e´thique en
expe´rimentation animale de Marseille (C2EA-14)). Heterozygote Tsc1wt/mut
(Tsc1þ / , National Cancer Institute (NCI, USA)) male mice were kindly provided
by Dr A. Bordey (Yale University, USA), and Tsc1flx/flx were obtained from Jackson
Laboratories. The genetic background of Tsc1wt/mut mice was B6;129S4 and Tsc1flx/
flx mice were from a mixed background (C57BL/6J, BALB/cJ, or 129/SvJae mice).
These lines of mice were generated by David J. Kwiatkowski (Brigham and
Women’s Hospital, Harvard Medical School, Cambridge, MA, USA). Inbred
C57BL/6J wild-type (Tsc1þ /þ ) females were from Janvier Labs (France). Mice
were housed in ventilated, light-tight, sound-isolated chambers under standard
12:12 light/dark cycle (light on at 07.00 PM and light off at 07.00 AM) with food
and water available ad libitum. Genotyping of pups issued from breading of
C57BL/6J Tsc1þ / males and C57BL/6J Tsc1þ /þ females mice was performed
on tail tissue samples at postnatal days P11–P12. The study was conducted in
Tsc1þ / and Tsc1þ /þ mice of both sexes issued from the same litters at P9–P33.
In utero electroporation. Timed pregnant female mice at the E16 (E0 is counted
as the morning on which the vaginal plug is detected) were anaesthetized with a
mixture of ketamine (10mg kg 1)/xylazine (100mg kg 1). The uterine horns
were exposed, and a lateral ventricle of each embryo was injected using pulled glass
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5563 ARTICLE
NATURE COMMUNICATIONS | 5:4563 | DOI: 10.1038/ncomms5563 | www.nature.com/naturecommunications 11
& 2014 Macmillan Publishers Limited. All rights reserved.
capillaries and a microinjector (Picospritzer II; General Valve) with Fast Green
(2mgml 1; Sigma, USA) combined with the following DNA constructs:
0.5mgml 1 pCAG-mRFP either alone or with 1.5mgml 1 pCAG-Cre:GFP.
Plasmids were further electroporated by discharging a 4,000-mF capacitor charged
to 35V with a BTX ECM 830 electroporator (BTX Harvard Apparatus). The
voltage was discharged in five electrical pulses at 950-ms intervals via 5-mm
electrodes placed on the head of the embryo across the uterine wall.
Quantitative RT–PCR. Total RNA was isolated from mouse cerebral cortex and
human brain tissue using RNeasy-Plus Mini Kit according to the manufacturer’s
protocol (Qiagen). cDNA was synthesized using the Quantitect Reverse
Transcription Kit, according to the manufacturer’s protocol (Qiagen). Quantitative
real-time RT-PCR experiments were performed using oligonucleotides specific
for mouse hypoxanthine phosphoribosyltransferase 1 and cyclophilin-A; human
b-actin and GAPDH, and mouse and human NMDAR subunits genes (oligonu-
cleotide sequences are shown in Supplementary Table 5). Amplification was done
using SYBR-Green and Chemistry (Roche Diagnostics) and Roche amplification
technology (Light Cycler 480). All experiments were performed in duplicate or
triplicate. To avoid any bias, all samples were blinded before analysis. Only after the
final samples were analysed and described, the samples were genotyped. Human
fetal brain and adult cerebral cortex mRNAs, used as controls, were purchased
from BD Biosciences Clontech (Palo Alto, CA, USA).
Animal slice preparation. Tsc1þ /þ and Tsc1þ / mice (P14–P16) were
anaesthetized with ether and killed by decapitation in agreement with the European
Directive 86/609/EEC requirements.
The brain was rapidly removed and placed in an oxygenated ice-cold saline
buffer. Transverse 300-mm-thick coronal slices were cut using a vibratome (Leica
VT1000S; Leica Microsystems Inc., Deerfield, IL, USA) in ice-cold protecting
solution oxygenated with 95% O2 and 5% of CO2. Before recording, slices were
incubated in an artificial cerebrospinal fluid (ACSF-1) solution containing (in
mM): 125 NaCl, 3.5 KCl, 1 CaCl2, 2 MgCl2, 1.25 NaH2PO4, 26 NaHCO3 and
10 glucose, equilibrated at pH 7.3 with 95% O2 and 5% CO2 at room temperature
(22–25 C) for at least 1 h to allow recovery. For the recordings, we used ACSF of
the same composition but with 2mM of CaCl2 and 1mM of MgCl2 (ASCF-2).
Immunostaining procedures. For immunostaining, P14–P16 mouse brains were
perfused with Anti-genfix solution and sliced at 100 mm on a vibratome (Microm).
Slices were blocked at room temperature for 1 h with 5% normal goat serum (NGS)
and 0.3% Triton X-100 in phosphate-buffered saline (PBS) and incubated over-
night at 37 C with the upper cortical layer marker CDP/CUX1 (M-222 Santa Cruz
Biotechnology; 1/200).
Human cortical slice preparation. After surgical resection, the cortical tissue was
placed within 30 s in ice-cold oxygenated protecting solution that contained in
(mM): 110 choline chloride, 26 NaHCO3, 10 D-glucose, 11.6 sodium ascorbate,
7 MgCl2, 3.1 sodium pyruvate, 2.5 KCl, 1.25 NaH2PO4 and 0.5 CaCl2, 300mOsm
and transported to the neurophysiology laboratory, within o5min. Cortical slices
(400–900 mm) were prepared in the same solution, and were then transferred to
holding chambers in which they were stored at room temperature (20–22 C) in
ACSF-1. Recordings were performed in ACSF-2.
Electrophysiological recordings from brain slices. Slices were transferred to
the recording chamber and perfused with oxygenated recording ACSF-2 at
3mlmin 1. Neurons were visualized using infrared differential interference
contrast microscopy. Whole-cell patch-clamp recordings were performed at
room temperature by using either an EPC-9 amplifier and Patch Master software
(HEKA Elektronik, Germany) or Multiclamp 700B amplifier (Molecular Devices,
Sunnyvale, CA, USA) and custom-made software based on IgorPro and filtered at
3–10 kHz. Patch pipettes were pulled from borosilicate glass capillaries (World
Precision Instruments, Sarasota, USA) and had resistances of 4–6.5MO when filled
with the internal solution of the following composition (in mM): 130 K-gluconate,
10 Na-gluconate, 4 NaCl, 4 MgATP, 4 phosphocreatine, 10 HEPES and 0.3 GTP
(pH 7.3 with KOH). Biocytin (final concentration 0.3–0.5%) was added to the
pipette solution to label the neurons from which recordings were obtained.
The series resistance estimated from the amplitude of the initial capacitive
transient in response to a 5-mV pulse was 8–24MO. It was not compensated and
was monitored during each experiment. Experiments were terminated if the series
resistance changed by 415%. Spontaneous EPSCs were recorded for 15min at
 80mV (the reversal potential for GABAergic currents) and at  50mV
(potential at which the block of NMDAR by magnesium is largely relieved). All
recordings were made in ACSF-2 without any proepileptic pharmacological drug.
To minimize potential sampling bias, the pups from at least three deliveries for
each condition were studied.
Analysis and statistics of in vitro data. The Mini Analysis 6.0.3 software
(Synaptosoft Inc., Decatur, GA, USA) was used to analyse the parameters of
synaptic events. The threshold amplitude for detecting EPSCs was set at twice the
baseline noise (root mean square), and the EPSCs detected by the software were
visually inspected to minimize errors. Events that did not show a typical synaptic
waveform were rejected manually.
For analysis, only events that did not show any signs of multiple peaks (that is,
contamination of rise or decay phases by subsequent events) were selected for
subsequent analysis of the kinetics and for exponential fitting.
Averaged traces of sEPSC or mEPSC and cumulative probabilities of amplitude
and frequency for all cells were obtained using (Mini Analysis; Synaptosoft)
software and further analysed with Origin software (MicroCal, Northampton, MA,
USA).
For each neuron, original traces from individual experiments were aligned
based on the starts of their rising phases and averaged. These averaged traces from
individual experiments were averaged to form grand average traces.
To quantify the current decay kinetics, we measured charge transfer of sEPSC
normalized by the peak amplitude. A larger charge transfer corresponds to slower
decay kinetics and vice versa. Normalized charge transfer was calculated by the
integrating the area under the current waveform in the interval of time between
peak of sEPSC and 300ms after the peak for each individual cell (Supplementary
Fig. 14).
In addition, to compare decay times between genotypes weighted time constant
of sEPSC or mEPSC decay (tw) were calculated using the formula (equation 1):
tW ¼ Ifast=ðIfast þ IslowÞð Þ tfastþ Islow=ðIslow þ IfastÞð Þtslow ; ð1Þ
where I is the amplitude of the fast or slow component, and t is the respective
decay time constant.
Data are expressed as mean±s.e.m. All comparisons were two-tailed t-tests or
one-way ANOVA with post hoc Fisher’s Least Significant Difference multiple
comparison. Statistical significance for cumulative probabilities was estimated
using Kolmogorov–Smirnov and Mann–Whitney tests. From three to nine animals
were used for each data set.
Immunocytochemistry. After the recording session, to visualize and identify the
recorded neurons, we visualized the biocytin injected during whole-cell recordings.
After 24 h in paraformaldehyde (3%) at 4 C, the sections were rinsed in PBS and
pre-incubated for 1 h in 0.3% Triton X-100 (Abcys) in PBS with 5% NGS at room
temperature. Slices were then incubated in Streptavidin-Cy3 (1:500) in PBS Triton
X-100 (0.3%) and NGS (5%) during 12 h at 4 C. After thorough rinsing, slices were
mounted in fluoromount and coverslipped.
In vivo recordings and data analysis. Experiments were performed on postnatal
days P9–P33 of inbred C57BL/6J strain of both sexes of Tsc1þ / and Tsc1wt mice
from the same litters issued from breading of Tsc1wt females and Tsc1þ / males.
The available littermates mice were randomly picked out of the cage and genotyped
after experiments. Surgery was performed under isoflurane anaesthesia. In brief,
the skull of the animal was cleaned of skin and periosteum. The skull was covered
by glue and dental cement except for a 4–9mm2 window above the somatosensory
cortex from one or two hemispheres. Two plastic bars were fixed to the nasal
and occipital bones of the pups head by dental cement. After surgery, animals
were warmed and were left for an hour for recovery from anaesthesia. During
recordings, the head was fixed to the frame of the stereotaxic apparatus by attached
bars; animals were surrounded by a cotton nest and heated via a thermal pad
(36.6–37.7 C). A silver chloride reference electrode was placed in the cerebellum or
visual cortex.
EEG recordings were performed in non-anaesthetized head-restrained
Tsc1þ / and control Tsc1wt mice. Sixteen site-linear silicon probe (100 mm
separation distance between recording sites, Neuronexus Technologies, MI, USA)
was placed into the somatosensory cortex using the Paxinos and Franklin atlas
(2001) at coordinates: anterior–posterior¼ 2–2.5mm, mediolateral¼ 2–3mm
from Bregma, 1.2–1.5mm depth, to trace the columnar activity at all layers and
CA1 zone of the hippocampus. Signals were amplified (  100) and filtered at
3 kHz using a 16-channel amplifier (A-M systems, Inc.), digitized at 10 kHz and
saved to hard disk of PC using Axoscope software (Molecular Devices). Recordings
were analysed offline using Clampfit and MATLAB software (The Mathworks,
Natick, MA, USA).
After the recordings, position of silicone probe was verified visually by DiI
staining of the electrode in 100 mm coronal sections from fixed brain. The actions
of UBP141 and DQP1105 were studied in vivo animal model of TSC in keeping
with recent guidelines for preclinical candidate drug evaluation67.
We considered that multiunit activity occurred in epileptic discharges if they
appeared in a group of multiple spikes whose amplitude exceeded at least twice the
background activity within a period lasting for at least 20 s. The first and last spikes
of each discharge were used to define its onset and termination, respectively. For
each discharge, amplitude was defined as the amplitude of the largest spike of the
discharge. During EEG recordings, animals were monitored visually to determine
behavioural correlates of each electrographic epileptic discharge.
For EEG data analysis, raw data were preprocessed using a custom-developed
suite of programs in the MATLAB analysis environment. The wide-band signal was
downsampled to 1,000Hz and used for local field potential (LFP) signal. Positive
polarity is graphed as up throughout the whole manuscript.
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LFPs were analysed by custom-written, MATLAB-based programs.
Approximate anatomical location of each recording site was estimated by physical
depth within the brain and corresponding age-matched histological assessment of
respective layers depth.
Negative epileptic events were detected by the following steps: (1) the LFP signal
was band-pass filtered (5–100Hz); (2) the times of negative troughs with amplitude
45 s.d. from baseline level were detected from filtered signal; and (3) aligned by
the times of detected negative epileptic events; the LFP segments from all channels
were taken. Note that the length of the segment is 200ms with moment of negative
trough at 0.
CSD analysis across cortical depth was used to eliminate volume conduction
and localize synaptic currents. CSD was computed for each recording site
according to differential scheme for second derivative and smoothed with a
triangular kernel of length 3.
Preliminary screen for UBP141 and DQP1105 efficacy in vivo. Saline solution
(200 ml), UBP141 (200 ml, 75mg kg 1) and DQP1105 (200 ml, 28mg kg 1) were
injected i.p. Using in silico prediction of blood–brain barrier permeation, we
estimated expected concentration of compounds in the brain. The decimal
logarithm of brain to blood concentration ratio (logBB) and drug concentration
relationship in the brain and blood (plasma) tissues were reconstructed using the
Clark’s equation68 to assess the logBB value for the UBP141 and DQP1105
compounds (equation (2)):
log BB ¼ 0:152ClogP 0:0148PSAþ 0:139; ð2Þ
where ClogP is a calculated octanol-water partitioning coefficient, and PSA is a
polar surface area (Supplementary Table 6 and Supplementary Fig. 15).
Both parameters were determined from molecular fields using the VolSurfþ
molecular modelling software programme (Molecular Discovery Ltd, Perugia,
Italy)69. According to this model the pharmacodynamic distribution of the drugs in
the brain after i.p. injection was assessed at least as 6.7% and 15% of the initial
concentration in blood for UBP141 and DQP1105, respectively.
On the other hand, according to ref. 70, the free-drug concentration in the
peritoneal cavity is described as its exponential decrease over distance (x) from the
serosal surface (peritoneum) since the drug diffuses down the concentration
gradient into the bloodstream (Supplementary Fig. 16). At characteristic diffusion
length,  0 (average distance travelled by drug molecules), the concentration
difference between tissue and blood is decreased to 37% of its maximum value.
Therefore, considering the decline of drug concentration at  0 due to
peritoneal transport, and the logBB values the distribution of DQP1105 in the brain
after i.p. injection can be assessed. Assuming DQP1105 concentration in injected
solution (2.5mM), volume of injection (200 ml) and total circulating blood volume
(ofB1,000 ml), concentration in brain will be around 25 mM that is entirely within
the selectivity range for GluN2C/D (Supplementary Table 1). Similar estimation for
UBP141 is complicated by the fact that effect of UBP141 (in contrast to DQP1105)
was delayed for 40min after i.p. injection, and unknown pharmacokinetic profile
could significantly influence the estimation.
Preliminary screen for efficacy of UBP141 and DQP1105 was also performed
directly to detect threshold for antiepileptic activity. In 12 animals tested, i.p.
injection of UBP141 with dosages of 19 or 57mg kg 1 did not produce significant
antiepileptic effects. In three animals tested, i.p. injection of DQP1105 with a
dosage of 14mg kg 1 was also ineffective. A dosage of 75mg kg 1 for UBP141
and 28mg kg 1 for DQP1105 were the lowest effective doses identified by testing
increasing doses of these compounds.
Multisite extracellular recordings from brain slices. Multisite extracellular
recordings of spontaneous activity in slices were performed at 30–32 C using
Multi-electrode array (MEA) made up of 60 planar microelectrodes (TiN/SiN,
30mm electrode diameter, 200 mm pitch) arranged over an 8 8 square grid (Multi
Channel Systems (MCS), Reutlingen, Germany). Slices were maintained in dishes
and perfused with oxygenated recording ACSF-2. The spontaneous activity was
monitored and recorded for 30–120min, starting 15–20min after setting slice in
the recording chamber at a stable level of activity. After 1,200 amplification
(MCS MEA 1060), signals were sampled at 10 kHz using the MCS data acquisition
card controlled by the MCS MCRack software. Data were analysed offline by using
custom software tools specifically developed in MATLAB .
Chemicals. All drugs were prepared as concentrated stock solutions (10–100mM),
stored frozen and then thawed and diluted in ACSF-2 immediately before use.
Ro-25697 (aR,bS)-a-(4-hydroxyphenyl)-b-methyl-4-(phenylmethyl)-1-piper-
idinepropanol maleate, and DQP1105 5-(4-bromophenyl)-3-(1,2-dihydro-6-
methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-g-oxo-1H-pyrazole-1-butanoic
acid were purchased from Tocris Biosciences (Bristol, UK). UBP 141 (2R*,3S*)-1-
(phenanthrenyl-3-carbonyl)piperazine-2,3-dicarboxylic acid was purchased from
Abcam Biochemicals (UK). All other chemicals used for electrophysiology were
from Sigma.
Treatment with rapamycin. Rapamycin (ready-made solution, Sigma-Aldrich,
USA, 2.5mgml 1 in DMSO (2.74mM)) was diluted with saline to a final
concentration 0.125mgml 1 immediately before use. The mice received single
dose of rapamycin (3mg kg 1) by i.p. injection (100 ml) or were injected by the
equal volume of vehicle once daily for 8 consecutive days. The electrophysiological
recordings were performed 24 h after the last administration.
Human subjects. Cortical tissue samples were obtained from three TSC epilepsy
patients undergoing surgery at the Departments of Pediatric Neurosurgery of
Rothschild Foundation (Paris) and Hopital La Timone (Marseille). Informed
consent for the use of postsurgical tissue for research purposes was obtained with
protocols approved by the Rothschild Foundation and Hopital La Timone review
boards. Personal data are stored into a specific database, which is declared to the La
Commission nationale de l’informatique et des liberte´s (CNIL). Bioethical
declaration procedure, related to conservation and preparation of human body
elements for scientific aims, was achieved during 2011 as referred to the ‘Collection
NeurochirEpilepsie‘ under file number DC-2011-1378, and has been approved by
Le Comite de Protection des Personnes Ile de France II and Ministe`re de
l’enseignement supe´rieur et de la recherche.
The main clinical and neuropathological characteristics of the study population
are summarized in Supplementary Tables 3 and 4. TSC and FCD specimens were
collected from patients who underwent surgery for medically intractable epilepsy.
All patients were clinically diagnosed with TSC and FCD and presented a history of
epilepsy.
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